Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Prostaglandin analogues attenuate ischemic liver damage in canine model

Oct. 29, 1998

Medeva seeks E.U. approval for third-generation hepatitis B vaccine

Oct. 28, 1998

Clinical testing of nonantibiotic anti-H. pylori agent will begin; development partner sought

Oct. 27, 1998

Shiseido claims pyrrolidines for gastric and peptic ulcers

Oct. 27, 1998

New study compares balsalazide to mesalamine

Oct. 26, 1998

Benzamides with antiulcer, antisecretory and anti-H. pylori effects discovered at Shiseido

Oct. 26, 1998

Antiulcer angucycline compound isolated from Streptomyces

Oct. 23, 1998

Rabeprazole effective for GERD and ulcers: data presented at gastroenterology congress

Oct. 19, 1998

Scripps uses DGT's gene expression technology to discover new treatments for HBV

Oct. 16, 1998

E.U. approval granted for rabeprazole; product launched in U.K.

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...